HEXAFLUORENIUM BROMIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for hexafluorenium bromide and what is the scope of patent protection?
Hexafluorenium bromide
is the generic ingredient in one branded drug marketed by Medpointe Pharm Hlc and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for hexafluorenium bromide.
Summary for HEXAFLUORENIUM BROMIDE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Patent Applications: | 1,184 |
DailyMed Link: | HEXAFLUORENIUM BROMIDE at DailyMed |
US Patents and Regulatory Information for HEXAFLUORENIUM BROMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medpointe Pharm Hlc | MYLAXEN | hexafluorenium bromide | INJECTABLE;INJECTION | 009789-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |